Stiripentol
Stiripentol is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Population Pharmacokinetics of Antiepileptic in Pediatrics
Stiripentol for the Treatment of Refractory Status Epilepticus
Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
Clinical Trials (8)
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Population Pharmacokinetics of Antiepileptic in Pediatrics
Stiripentol for the Treatment of Refractory Status Epilepticus
Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
Compassionate Use of Stiripentol in Dravet Syndrome
Stiripentol in Dravet Syndrome
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8